Shiksha Nation
Skip to content

Atrasentan

Chemical compound

  • 1 min read
  • 3 chapters

Related on Lably

Through Medication and Cancer

Atrasentan was approved for medical use in the United States for IgA nephropathy in April 2025.

Medical uses

Atrasentan is indicated to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progression, generally a urine protein-to-creatinine ratio >= 1.5 g/g.

Sign up free to read the rest

2 more chapters are free with a Lably account.

Already have an account?

More in Health